Browse by Aston Author

Article

Curti, Carlo, Kirby, Daniel j. and Russell, Craig a. (2024). Systematic screening of photopolymer resins for Stereolithography (SLA) 3D printing of solid oral dosage forms: investigation of formulation factors on printability outcomes. International Journal of Pharmaceutics, 653 ,

Khan, Dilawar, Badhan, Raj, Kirby, Daniel J., Bryson, Simon, Shah, Maryam and Mohammed, Afzal Rahman (2023). Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use. Pharmaceutics, 15 (2),

Khan, Dilawar, Kirby, Daniel, Bryson, Simon, Shah, Maryam and Rahman Mohammed, Afzal (2022). Paediatric specific dosage forms: Patient and formulation considerations. International Journal of Pharmaceutics, 616 ,

Khan, Dilawar, Kirby, Daniel, Bryson, Simon, Shah, Maryam and Mohammed, Afzal Rahman (2021). Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations. Pharmaceutics, 13 (6),

Curti, Carlo, Kirby, Daniel J. and Russell, Craig A. (2021). Stereolithography Apparatus Evolution: Enhancing Throughput and Efficiency of Pharmaceutical Formulation Development. Pharmaceutics, 13 (5),

Ershad, Abdul, Rajabi-Siahboomi, Ali, Missaghi, Shahrzad, Kirby, Daniel J and Mohammed, Afzal-Ur-Rahman (2021). Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence. Pharmaceutics, 13 (3),

Dahmash, Dania Talaat, Shariff, Zakia B, Kirby, Daniel J, Terry, David and Huynh, Chi (2020). Literature review of medication administration problems in paediatrics by parent/caregiver and the role of health literacy. BMJ Paediatrics Open, 4 (1),

Shariff, Zakia, Kirby, Daniel, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali and Maidment, Ian (2020). Patient-Centric Medicine Design: Key Characteristics of Oral Solid Dosage Forms that Improve Adherence and Acceptance in Older People. Pharmaceutics, 12 (10),

Shariff, Zakia B, Dahmash, Dania T, Kirby, Daniel J, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali and Maidment, Ian D (2020). Does the Formulation of Oral Solid Dosage Forms Affect Acceptance and Adherence in Older Patients?:A Mixed Methods Systematic Review. Journal of the American Medical Directors Association, 21 (8), 1015-1023.e8.

Curti, Carlo, Kirby, Daniel J. and Russell, Craig A. (2020). Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing. Progress in Additive Manufacturing, 5 (2), pp. 111-123.

Miriyala, Nikhila, Kirby, Daniel J., Cumont, Aude, Zhang, Ruoying, Shi, Baogui, Ouyang, Defang and Ye, Haitao (2020). Synthesis of Carbon Onion and Its Application as a Porous Carrier for Amorphous Drug Delivery. Crystals, 10 (4),

Koner, Jasdip, Rajabi-Siahboomi, Ali, Missaghi, S., Kirby, Daniel J, Perrie, Yvonne, Ahmed, J. and Mohammed, Afzal (2019). Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets. Scientific Reports, 9 ,

Joshi, Sameer, Bawage, Swapnil, Tiwari, Pooja, Kirby, Daniel, Perrie, Yvonne, Dennis, Vida and Singh, Shree R (2019). Liposomes:a promising carrier for respiratory syncytial virus therapeutics. Expert Opinion on Drug Delivery, 16 (9), pp. 969-980.

Joshi, Sameer, Chaudhari, Atul A, Dennis, Vida, Kirby, Daniel J, Perrie, Yvonne and Singh, Shree Ram (2018). Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus. Bioengineering (Basel, Switzerland), 5 (2),

Miriyala, Nikhila, Ouyang, Defang, Perrie, Yvonne, Lowry, Deborah and Kirby, Daniel J. (2017). Activated carbon as a carrier for amorphous drug delivery:effect of drug characteristics and carrier wettability. European Journal of Pharmaceutics and Biopharmaceutics, 115 , 197–205.

Joshi, Sameer, Hussain, Maryam T., Roces, Carla B., Anderluzzi, Giulia, Kastner, Elisabeth, Salmaso, Stefano, Kirby, Daniel J. and Perrie, Yvonne (2016). Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs. International Journal of Pharmaceutics, 514 (1), pp. 160-168.

Koner, Jasdip S., Rajabi-Siahboomi, Ali, Bowen, James, Perrie, Yvonne, Kirby, Daniel and Mohammed, Afzal R. (2015). A holistic multi evidence approach to study the fragmentation behaviour of crystalline mannitol. Scientific Reports, 5 ,

Al-Khattawi, Ali, Koner, Jasdip, Rue, Peter, Kirby, Dan, Perrie, Yvonne, Rajabi-Siahboomi, Ali and Mohammed, Afzal R. (2015). A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance. European Journal of Pharmaceutics and Biopharmaceutics, 94 , pp. 1-10.

Ali, M. Habib, Moghaddam, Behfar, Kirby, Daniel J., Mohammed, Afzal R. and Perrie, Yvonne (2013). The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. International Journal of Pharmaceutics, 453 (1), pp. 225-232.

Kirby, Daniel J., Kaur, Randip, Agger, Else M., Andersen, Peter, Bramwell, Vincent W. and Perrie, Yvonne (2013). Developing solid particulate vaccine adjuvants - surface bound antigen favouring a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity. Current drug delivery, Epub a ,

Kirby, Daniel J., Kaur, Randip, Agger, Else M., Andersen, Peter, Bramwell, Vincent W. and Perrie, Yvonne (2013). Developing solid particulate vaccine adjuvants:surface bound antigen favouring a humoural response, whereas entrapped antigen shows a tendency for cell mediated immunity. Current Drug Delivery, 11 (6), pp. 268-278.

Ali, M. Habib, Moghaddam, Behfar, Kirby, Daniel J., Mohammed, Afzal R. and Perrie, Yvonne (2012). The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. International journal of pharmaceutics, in pre ,

Davidsen, Jesper, Rosenkrands, Ida, Christensen, Dennis, Vangala, Anil K., Kirby, Daniel, Perrie, Yvonne, Agger, Else M. and Andersen, Peter (2005). Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′- dibehenate) - A novel adjuvant inducing both strong CMI and antibody responses:a novel adjuvant inducing both strong CMI and antibody responses. BBA -Biomembranes, 1718 (1-2), pp. 22-31.

Thesis

Kirby, Daniel J. (2007). Formulation and characterisation of an effective particulate delivery vehicle for the novel sub-unit vaccine antigen, Ag85B-ESAT-6. PHD thesis, Aston University.